The largest database of trusted experimental protocols

21 protocols using inertsil ods 4

1

Plasma Amino Acid Profiling by HPLC

Check if the same lab product or an alternative is used in the 5 most similar protocols
An 8-mL sample of whole blood was collected from each participant before noon and placed into BD Vacutainer® CPT™ cell preparation tubes containing sodium heparin (Becton, Dickinson Co., Plainfield, NJ, USA). Plasma samples were isolated from the whole blood samples according to the tube manufacturer's instructions and subsequently stored at −80 °C. The concentrations of glutamine, glutamate, and glycine were measured using an H-class high-performance liquid chromatography (HPLC) system (Waters Corporation) equipped with a quaternary pump, autosampler with the cooler set at <10 °C, column oven, and fluorescence detector. The analytical HPLC column used was Inertsil ODS-4 (2 μm, 2.1 × 100 mm, G.L. Sciences Inc.) with a guard column packed with Inertsil ODS-4 material (2 μm, 2.1 × 10 mm, G.L. Sciences Inc.), maintained at 40 °C. The plasma levels of l-serine and d-serine were also measured using the same HPLC system, except the analytical HPLC column used was Sumichiral OA2500S (5 μm, 4.6 × 250 mm, Sumika Analytical Center), maintained at 40 °C. Amino acids were labeled with 4-fluoro-7-nitro-benzoxazole, while homocysteine was labeled with 4-fluoro-7-sulfamoylbenzofurazan; they were measured according to the protocol presented in a previous study [18 (link)]. All chemicals for HPLC analyses were purchased from Sigma-Aldrich Japan (Tokyo, Japan), unless otherwise indicated.
+ Open protocol
+ Expand
2

Quantification of Metabolites in CAF Supernatants

Check if the same lab product or an alternative is used in the 5 most similar protocols
To determine the quantities of specific metabolites in supernatants of CAF, HPLC analyses were also carried out. Supernatants of CAF cultures were mixed with the internal standard 2‐oxovalerate and reacted with 10 mmol/L o‐phenylenediamine in 2‐mol/L HCl for 20 minutes at 80°C. Samples were desiccated with sodium sulfate, dried in vacuum, and re‐solubilized in methanol for HPLC analysis. Fluorescent derivatives were separated on an HPLC system comprising a pump (PU‐1580; JASCO, Tokyo, Japan), an auto sampler (AS920; JASCO), a column oven (CO980; JASCO), and a fluorescence detector (FP1520; JASCO). HPLC was carried out on an octadecylsilica column (Inertsil ODS‐4, 250 × 3.0 mm internal diameter, 5 μm; GL Sciences, Tokyo, Japan) at 40°C with a flow rate of 0.6 mL/min, using a mobile phase comprising water/methanol (55/45, v/v).
+ Open protocol
+ Expand
3

Quantifying Singlet Oxygen Production

Check if the same lab product or an alternative is used in the 5 most similar protocols
The fluorescence intensity of SOSG (Thermo Fisher Scientific, Waltham, MA, USA) oxidized by 1O2 was determined from the fluorescence of the HPLC peaks. The photocatalyst (2 µM) and SOSG (10 µM) were added to 50% CH3CN solution in 10 mM MES buffer (pH 7.4) in a 1.5 mL tube. The solution was irradiated with blue light (RELYON, Twin LED light, 455 nm) for 30 s on ice. After irradiation, the solution was diluted 2.6-fold with 0.1% aqueous formic acid and analyzed using HPLC. Analytical HPLC was carried out on a JASCO PU-4580 HPLC Pump, JASCO LG-4580 Quaternary Gradient Unit (Tokyo, Japan), and JASCO DG-4580 Degassing Unit with a JASCO MD-2018 Plus Photodiode Array Detector, JASCO CO-4060 Column Oven, JASCO As-455 HPLC Autosampler, and JASCO LC-NetII/ADC Interface Box using a C18 reverse phase column (Inertsil ODS-4, 150 × 4.6 mm, 5 μm (GL Science, Inc., Tokyo, Japan)). The HPLC conditions were as follows: mobile phase A, 0.1% formic acid in H2O, mobile phase B, 0.1% formic acid in CH3CN. 0−5 min, 5% B; 5−27 min, 5−100% B; 27−32 min, 100% B. The fluorescence of the separated peaks was detected using HPLC (Ex 504 nm/Em 525 nm).
+ Open protocol
+ Expand
4

Measurement of Urinary Catecholamines and Metabolites

Check if the same lab product or an alternative is used in the 5 most similar protocols
We determined the concentration of urinary CAs (noradrenaline and adrenaline) and their metabolites by treatment with sulfatase from Helix pomatia Type H-2 (Sigma Aldrich, St. Louis, MO) according to a previous report.(20 (link)) Briefly, the urine was heated for 10 min following incubation with 500 U/ml of the enzyme at 37°C for 1 h. After the addition of isoprenaline (Sigma Aldrich, Milwaukee, WI) as the internal standard, CAs were purified using Monospin PBA® (GL Sciences, Tokyo Japan). The HPLC system (Prominance HPLC System Shimazu Corporation, Kyoto Japan) consisted of a quaternary pump with a vacuum degasser, thermostatted column compartment, and an autosampler equipped with an electrochemical detector (ECD 700 S; Eicom Corporation, Kyoto, Japan). A reverse-phase column (Inertsil ODS-4, 250 × 3.0 mm ID, 5 μm; GL Sciences) was used and the column temperature was maintained at 35°C. The HPLC mobile phase was 24 mM acetate-citrate buffer (pH 3.5, -CH3CN, 100/14.1 v/v). The mobile phase flow rate was 0.3 ml/min and the injection volume 20 μl. The eluents were detected and analyzed at 500 mV. Excretion of CA was expressed as a ratio with the urinary creatinine concentration measured using Laboassay creatinine (FUJIFILM Wako Pure Chemical Corporation).
+ Open protocol
+ Expand
5

Analysis of Phenolic Compounds by LC-MS/MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dry filtrates were diluted to 1000 mg/L and filtered with a 0.2 µm microfiber filter prior to LC-MS/MS analysis [31 (link)]. LC-MS/MS analyses of the phenolic compounds were performed using a Nexera model Shimadzu UHPLC coupled to a tandem MS instrument (Shimadzu, Kyoto, Japan). The liquid chromatography was equipped with LC-30AD binary pumps (Shimadzu, Kyoto, Japan), a DGU-20A3R degasser (Shimadzu, Kyoto, Japan), a CTO-10ASvp column oven (Shimadzu, Kyoto, Japan), and a SIL-30AC auto sampler (Shimadzu, Kyoto, Japan). The chromatographic separation was performed on a C18 reversed-phase Inertsil ODS-4 (150 mm × 4.6 mm, 3 µm, GL Sciences, Tokyo, Japan) analytical column. The column temperature was fixed at 40 °C. The elution gradient consisted of mobile phase A (water, 5 mM ammonium formate and 0.1% formic acid) and mobile phase B (methanol, 5 mM ammonium formate, and 0.1% formic acid). The gradient program with the following proportions of solvent B was applied t (min), B%: (0, 40), (20, 90), (23.99, 90), (24, 40), (29, 40). The solvent flow rate was maintained at 0.5 mL/min and injection volume was set as 4 µL.
+ Open protocol
+ Expand
6

Plasma Catecholamines Quantification by HPLC-ECD

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma catecholamines were analyzed by HPLC-electrochemical detection (ECD) after being prepared with a monolithic silica disk-packed spin column (MonoSpin, GL Science, Tokyo Japan) [25] (link). Norepinephrine and epinephrine were obtained from Tokyo Kasei (Tokyo, Japan). Dopamine was acquired from Wako Pure Chemical (Topkyo, Japan). The 3,4-dihydroxybenzylamine (DHBA) used was from (Sigma Aldrich, Japan). Acetonitrile was purchased from Wako Pure Chemical (Tokyo, Japan). Plasma, 1 M phosphate buffer (pH 8.0) (50 µL), and 400 ng/mL DHBA (internal standard; 40 µL) were directly injected into the pre-activated spin column which was centrifuged at 3000 rpm for 5 min. The column was then rinsed with 200 µL of 100 mM phosphate buffer (pH 8.0) by centrifugation. Finally, the column was installed into a new microtube, and the analytes that were adsorbed onto the column were eluted with 1% acetic acid (200 µL). A 20 µL aliquot of the eluate was njected into the HPLC system (Prominance HPLC System Shimazu Corporation, Kyoto Japan) equipped with ECD (ECD 700 S, Eicom Corporation, Kyoto Japan) set at 650 mV. HPLC separation was conducted on an Inertsil ODS-4 (250×3.0 mm I.D., 5 µm) (GL Science) at 35°C, with a flow rate of 0.5 mL/min using a mobile phase comprised of 20 mM sodium acetate-citrate buffer/Acetonitrile (100/16, v/v) containing 1 g/L sodium 1-octanesulfonate.
+ Open protocol
+ Expand
7

Glycopeptide Analysis by UPLC-MS/MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
UPLC–MS/MS data were acquired on an UPLC system (Agilent HP1200; Agilent Technologies, Palo Alto, CA, USA) equipped with a C18 column (Inertsil ODS-4, 2 μm, 100 Å, 100 mm × 1.5 mm ID; GL Science, Tokyo, Japan) and coupled with an electrospray ionization quadrupole time-of-flight (Q-TOF) mass spectrometer (Agilent 6520, Agilent Technologies). Solvent A was 0.1% formic acid, and solvent B comprised 0.1% formic acid in 9.9% water and 90% acetonitrile. Glycopeptides were eluted at 40 °C with a flow rate of 0.15 mL/min, using the following gradient program: 0–7 min, 15–30% solvent B; 7–12 min, 30–50% solvent B; and an additional 2-min hold at 100% solvent B. The mass spectrometer was operated in negative mode with a capillary voltage of 4000 V. The nebulizing gas pressure was 30 psi, and the dry gas flow was 8 L/min at 350 °C. The injection volume was 5 μL.
+ Open protocol
+ Expand
8

LC-MS/MS Analysis of Metabolites

Check if the same lab product or an alternative is used in the 5 most similar protocols
LC-MS/MS analyses were performed with an UPLC system (Nihon Waters, Tokyo, Japan) coupled with a tandem Xevo TQ-S micro mass spectrometer (Nihon Waters, Tokyo, Japan). The UPLC mobile phases consisted of 0.1% formic acid in DW (A) and 0.1% formic acid in acetonitrile (B) (60% solvent B; flow rate, 0.2 mL/min; column oven, 40 °C, injection volume, 2 μL). The column used for the separation was an Inertsil ODS-4, 3 μm (ϕ 2.1 × 100 mm, GL Science). For 1 detection, MS analysis was performed in the positive mode with the following source parameters: cone voltage, 76 V; collision energy, 28 V (m/z 279 > 236). For 2 detection, MS analysis was performed in the positive mode with the following source parameters: cone voltage, 32 V; collision energy, 28 V (m/z 249 > 130). For 3 detection, MS analysis was performed in the positive mode with the following source parameters: cone voltage, 76 V; collision energy, 28 V (m/z 265 > 146). The following source parameters were common to all the compounds: capillary voltage, 3.0 kV; desolvation temperature, 500 °C; desolvation gas flow, 1000 L/h; cone gas flow, 50 L/h.
+ Open protocol
+ Expand
9

Glycopeptide Analysis by UPLC-MS/MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
The data of UPLC-MS/MS were acquired on a UPLC system (Agilent HP1200; Agilent Technologies, Palo Alto, CA, USA) equipped with a C18 column (Inertsil ODS-4, 2 μm, 100 Å, 100 × 1.5 mm i.d.; GL Science, Tokyo) and coupled with an electrospray ionization quadrupole time-of-flight mass spectrometer (Agilent 6520, Agilent Technologies). Solvent A was 0.1% formic acid, and solvent B comprised 0.1% formic acid in 9.9% water and 90% acetonitrile. Glycopeptides were eluted at 40°C and a flow rate of 0.15 mL/min, using the following gradient program: 0–7 min, 15–30% solvent B; 7–12 min, 30-50% solvent B; and an additional 2 min hold at 100% solvent B. The mass spectrometer was operated in negative mode with a capillary voltage of 4000 V. The nebulizing gas pressure was 30 psi, and the dry gas flow was 8 L/min at 350°C. The injection volume was 5 μL. The precursor ions (m/z) and collision energies of A1813 and A1958 were set at 1813.7 and 60 V, and 1958.25 and 60 V, respectively. Extracted ion chromatography data were obtained in the following m/z ranges: 1808.4–1810.5 for A1813, and 1885.7–1887.7 for A1958. A1958 and A1813 values were normalized to the corresponding values in serum from a healthy female control.
+ Open protocol
+ Expand
10

Glycopeptide Analysis by UPLC-MS/MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
The data of UPLC-MS/MS were acquired on a UPLC system (Agilent HP1200; Agilent Technologies, Palo Alto, CA, USA) equipped with a C18 column (Inertsil ODS-4, 2 μm, 100 Å, 100 × 1.5 mm i.d.; GL Science, Tokyo) and coupled with an electrospray ionization quadrupole time-of-flight mass spectrometer (Agilent 6520, Agilent Technologies). Solvent A was 0.1% formic acid, and solvent B comprised 0.1% formic acid in 9.9% water and 90% acetonitrile. Glycopeptides were eluted at 40°C and a flow rate of 0.15 mL/min, using the following gradient program: 0–7 min, 15–30% solvent B; 7–12 min, 30-50% solvent B; and an additional 2 min hold at 100% solvent B. The mass spectrometer was operated in negative mode with a capillary voltage of 4000 V. The nebulizing gas pressure was 30 psi, and the dry gas flow was 8 L/min at 350°C. The injection volume was 5 μL. The precursor ions (m/z) and collision energies of A1813 and A1958 were set at 1813.7 and 60 V, and 1958.25 and 60 V, respectively. Extracted ion chromatography data were obtained in the following m/z ranges: 1808.4–1810.5 for A1813, and 1885.7–1887.7 for A1958. A1958 and A1813 values were normalized to the corresponding values in serum from a healthy female control.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!